CNS toxicity remains one of the leading causes of failure in drug development, yet it is rarely detected in preclinical studies. Among these risks, seizure liability is one of the most challenging and ...
Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...
Contrary to prior work, principal axes of structural and functional connectivity are established early in life, remaining stable and undergoing refinement throughout development.
CRISPR-based screening in drug discovery provides a robust methodology for unbiased, high-throughput interrogation of gene function. This technology enables researchers to identify and validate ...
Physical therapy modalities—from ultrasound to cryotherapy—can play a key role in pain relief, recovery, and functional improvement when used in the right context. Current clinical resources highlight ...
Data highlight advancements across ElevateBio's targeted gene insertion platform, powered by retrotransposon and machine learning-optimized recombinase approaches, and its new epigenetic editing ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...